✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Bharat Parenterals Ltd.

BPLPHARMA

Market Cap
₹930 Cr.
P/E
0.00

Bharat Parenterals Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
930 Cr
PE
PE
-
Prom Holding
Prom Holding
67.17 %
ROE (%)
ROE (%)
-
ROCE (%)
ROCE (%)
-4.90
Div Yield (%)
Div Yield (%)
0.07
Sales
Sales
345 Cr
OPM (%)
OPM (%)
4.58 %
Debt to Equity
Debt to Equity
0.55
Institutions
Institutions
1.17 %
Individual < 2 lac
Individual < 2 lac
13.76 %
No. of Shareholders
No. of Shareholders
3,095
View more
Edit Ratio's

About

Bharat Parenterals limited is dealing in Manufacturing of Pharmaceutical Formulations. The com… Read more
Low
880
52W Range
High
1667
  • Bharat Parenterals
  • Wanbury
  • Anuh Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

3 Yes

Positive for this company

3 Neutral

Neutral for this company

10 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Customers

    • Alembic Pharmaceuticals Ltd.
    • Sun Pharmaceutical Industries Ltd.

    FAQs on Bharat Parenterals Ltd. Business

    Bharat Parenterals Limited specializes in manufacturing pharmaceutical formulations for domestic and international markets, aiming to become a leading company by providing high-quality products meeting customer and regulatory standards.

    Bharat Parenterals major competitors are Wanbury, Anuh Pharma, Zim Laboratories, Kilitch Drugs(India), Lincoln Pharma, Syncom Formulations, Jenburkt Pharma.
    Market Cap of Bharat Parenterals is ₹930 Crs.
    While the median market cap of its peers are ₹786 Crs.

    Bharat Parenterals seems to be less financially stable compared to its competitors.
    Altman Z score of Bharat Parenterals is 3.35 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Jan May Jul Nov Jun Sep Dec
    Investor Presentation Jan May Jul Nov Mar Dec
    Conference Call May Mar Nov
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Bharat Parenterals Ltd.
    Bharat Parenterals: Building a Pharma Powerhouse | The Spotlight ft. Bhahim Desai - Krish Kothari
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material